Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1016/j.atherosclerosis.2019.08.014

Type

Journal

Atherosclerosis

Publication Date

11/2019

Volume

290

Pages

140 - 205

Keywords

Apolipoprotein B, Cholesterol;, Dyslipidaemias, Familial hypercholesterolaemia, Guidelines, High-density lipoproteins, Lipoprotein remnants, Lipoprotein(a), Low-density lipoproteins, Total cardiovascular risk, Treatment (adherence), Treatment (drugs), Treatment (lifestyle), Triglycerides, Very low-density lipoproteins, Adult, Aged, Biomarkers, Cardiovascular Diseases, Consensus, Drug Therapy, Combination, Dyslipidemias, Female, Humans, Hypolipidemic Agents, Lipids, Male, Middle Aged, Risk Assessment, Risk Factors, Risk Reduction Behavior, Treatment Outcome